Welcome to our dedicated page for XEBRA BRANDS news (Ticker: XBRAF), a resource for investors and traders seeking the latest updates and insights on XEBRA BRANDS stock.
XEBRA Brands Ltd. is a leading cannabis company that focuses on providing high-quality CBD products to consumers globally. The company recently signed a manufacturing agreement with Restorative Botanicals, marking a significant milestone as it expands its product portfolio. This collaboration will introduce premium CBD tinctures to the Mexican market, with products crafted to meet XEBRA's specifications. The company aims to manufacture locally in Mexico in the future but is currently importing products to meet consumer demands. XEBRA's commitment to quality and innovation is highlighted through its collaboration with Restorative Botanicals, a renowned provider of premium CBD products.
Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has successfully harvested its first cannabis crop in the Netherlands, comprised of high THC and THC-CBD balanced flowers. The samples were submitted to the Bureau of Medicinal Cannabis on March 25, 2022. As one of five companies selected for a Dutch government pilot trial, Xebra aims to secure one of two licenses, potentially generating at least ~US$80 million in guaranteed revenue. Further crops are planned for submission, with the next deadline set for September 19, 2022, and a decision on licenses expected by April 3, 2023.
Xebra Brands Ltd. (CSE: XBRA) has secured a significant milestone with the Supreme Court of Mexico issuing a final resolution granting an injunction to its subsidiary, Desart MX, SA de CV. This decision solidifies Xebra's first-mover advantage in the emerging Mexican cannabis market, particularly in the industrial cannabis sector, focusing on low-THC products. Following previous unanimous support from the Supreme Court, the company aims to initiate formal cannabis operations within 2022, leveraging Mexico's potential as a major cannabis consumer market and its favorable manufacturing costs compared to North America.
Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC) has announced that its cannabis cultivation in the Netherlands is in the flowering stage, with samples to be submitted to Dutch authorities by the end of March. As one of five select companies in a government pilot trial, Xebra aims to secure one of two licenses, potentially generating revenues of up to ~US$80 million over six years. The company emphasizes automation in cultivation for consistent quality, with its operations led by industry expert Harry von Duijne, previously with Bedrocan NL.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announced plans to launch its cannabis beverage, Vicious Citrus Lemonade, in Canada, targeting Alberta, British Columbia, and Ontario. This beverage contains 10mg of THC and 2mg of CBN per serving, offering a unique consumption experience due to the synergistic effects of cannabinoids. Vicious Citrus Lemonade is notably among the few beverages with CBN in Canada and utilizes tested emulsion IP. Production is set to start in spring 2022, aiming for a summer launch, with positive feedback from provinces and dispensaries noted.
Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has achieved eligibility for DTC services, enhancing the liquidity of its shares for U.S. investors. This development simplifies the trading process and reduces costs for investors and brokers, allowing wider access to Xebra's shares. President Rodrigo Gallardo noted this as a significant milestone in increasing corporate visibility and facilitating U.S. investment in the company. DTC serves as a clearinghouse for electronically traded securities in the U.S., streamlining settlements.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announces a non-brokered private placement aiming for gross proceeds of up to CAD$1,200,000. The offering consists of up to 10,000,000 units priced at CAD$0.12 per unit, each unit containing one common share and a half warrant. Each full warrant can be exercised to buy a common share at CAD$0.25 for 12 months. The proceeds will be allocated for general working capital. The placement is subject to Canadian Securities Exchange approval.
Xebra Brands Ltd. (CSE: XBRA) has announced the granting of trademarks for its cannabis-infused beverage brands in various Latin American countries, including Argentina, Brazil, and Colombia. The trademarks include names such as MADCAP for soft drinks and VICIOUS CITRUS for lemonades, along with catchy slogans. This move supports Xebra's strategy to secure global trademark protection as cannabis legalization expands. The company is also focused on launching its products in Canada and completing agronomical evaluations in Colombia for future cannabis activities.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has completed all conditions to license its Solutech™ technology from New Age Nanotech. This patent-pending cannabinoid emulsion technology converts cannabis extracts into shelf-stable, water-soluble forms for beverages and edibles. Unique for its completion of a Phase-I human clinical trial, Solutech™ is poised for commercialization, starting with the launch of Vicious Citrus THC Lemonade in Canada in Spring 2022. Xebra holds exclusive rights for production in Mexico and Colombia and non-exclusive rights in Europe and the Americas.
Xebra Brands Ltd. (OTCQB: XBRAF) announced the granting of trademarks in the European Union for its THC and CBD-infused beverage brands, covering 28 countries and 10 territories. The trademarks include MADCAP soft drinks, HOLAHI iced teas, HIGHJACK energy drinks, VICIOUS CITRUS lemonades, and HIGHCASTLE waters, along with the CONQUER CBD sports drink. Xebra also holds a cannabis injunction from the Mexican Supreme Court, positioning it strongly in Mexico's CBD and CBG sectors. The company has plans to launch Vicious Citrus lemonade in Canada in spring 2022 and is evaluating cannabis seed varieties in Colombia.
Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has completed its 100% acquisition of Desart MX, issuing 48 million shares to Mexican vendors, held in escrow for 38 months. Desart secured an irrevocable injunction from the Mexican Supreme Court, giving it a first-mover advantage in the CBD and CBG market, allowing for low-THC cannabis cultivation. Xebra plans to secure land for cultivation and explore joint ventures with US and Canadian companies, aiming to leverage Mexico's position within the North American market.
FAQ
What is the current stock price of XEBRA BRANDS (XBRAF)?
What is the market cap of XEBRA BRANDS (XBRAF)?
What is XEBRA Brands Ltd. focused on?
What recent milestone did XEBRA achieve?
What is the goal of the collaboration with Restorative Botanicals?
How does XEBRA plan to manufacture products in the future?